GLP-1 medications influence multiple metabolic pathways, including insulin secretion, glucose regulation, and energy expenditure
The first-time prescribing rates of ADM decreased (-4.4%), while the rates of AOM increased (+65.1%)
doi: 10.3390/ijms19061804 57
Lowest effective dose tailored to you Fewer side effects minimal nausea, fatigue Better protein intake & muscle preservation Dose adjusted based on labs & response Hormone & root-cause investigation Built-in exit strategy from medication Sustainable, long-term results Fixed escalation regardless of response More nausea, vomiting, fatigue Significant muscle loss reported No labs, no individual monitoring Hormones & root causes never addressed No plan to come off medication Weight regain when medication stops How the 12-Week Program Works From your first consultation to your final follow-up, every step is designed to produce lasting results
Good so far
and in dark, leafy greens